Hosted at Ricoh 3D for Healthcare, Frontiers in BioInnovation brought together pioneers in bioprinting, regenerative medicine, and medtech regulation for a thought-provoking conversation on translating scientific breakthroughs into scalable, real-world healthcare solutions.
Panelists from Ronawk, NIST, Wake Forest Institute for Regenerative Medicine, and Ricoh 3D for Healthcare discussed how to build the infrastructure for biomanufacturing at scale, develop standards for bioinks and tissue-mimetic materials, advance personalized medicine and point-of-care 3D printing, and navigate regulatory pathways that accelerate innovation while ensuring safety.
With perspectives spanning academia, startups, government standards, and applied clinical innovation, the panel delivered a nuanced, forward-looking view of what it takes to turn biotechnology into impact.
Unlock the Full Potential of Additive Manufacturing with Our Business Case Toolkit
Our Additive Manufacturing (AM) Business Case Toolkit provides practical templates, worksheets, and strategic guidance to help you validate, justify, and implement AM in your organization. With tools like ROI and feasibility calculators, stakeholder messaging guide, and more, you’ll build a data-driven, compelling business case for AM adoption. Built out of experience and insights from an expert panel including Medtronic, Thermo Fisher, and others, this toolkit supports teams in evaluating technology, aligning with organizational goals, and securing cross-functional buy-in, ensuring a smooth transition to AM integration with actionable insights for successful implementation.
